These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 8204658)

  • 1. Studies of in vitro gamma-interferon production in coeliac disease as a response to gliadin peptides.
    Cornell HJ; Skerritt JH; Puy R; Javadpour M
    Biochim Biophys Acta; 1994 May; 1226(2):126-30. PubMed ID: 8204658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amino acid composition of gliadin fractions which may be toxic to individuals with coeliac disease.
    Cornell HJ; Maxwell RJ
    Clin Chim Acta; 1982 Aug; 123(3):311-9. PubMed ID: 6811164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The activity of wheat gliadin peptides in in vitro assays for coeliac disease.
    Cornell HJ; Mothes T
    Biochim Biophys Acta; 1993 Apr; 1181(2):169-73. PubMed ID: 8481406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the gliadin-derived peptides which are biologically active in coeliac disease.
    Cornell H; Wieser H; Belitz HD
    Clin Chim Acta; 1992 Dec; 213(1-3):37-50. PubMed ID: 1477986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activities of A-gliadin-related synthetic peptides: damaging effect on the atrophic coeliac mucosa and activation of mucosal immune response in the treated coeliac mucosa.
    Maiuri L; Troncone R; Mayer M; Coletta S; Picarelli A; De Vincenzi M; Pavone V; Auricchio S
    Scand J Gastroenterol; 1996 Mar; 31(3):247-53. PubMed ID: 8833354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The toxic fraction of gliadin digests in coeliac disease. Isolation by chromatography on Biogel P-10.
    Jos J; Charbonnier L; Mossé J; Olives JP; de Tand MF; Rey J
    Clin Chim Acta; 1982 Mar; 119(3):263-74. PubMed ID: 6802520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo antigen challenge in celiac disease identifies a single transglutaminase-modified peptide as the dominant A-gliadin T-cell epitope.
    Anderson RP; Degano P; Godkin AJ; Jewell DP; Hill AV
    Nat Med; 2000 Mar; 6(3):337-42. PubMed ID: 10700238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 31-43 amino acid sequence of the alpha-gliadin induces anti-endomysial antibody production during in vitro challenge.
    Picarelli A; Di Tola M; Sabbatella L; Anania MC; Di Cello T; Greco R; Silano M; De Vincenzi M
    Scand J Gastroenterol; 1999 Nov; 34(11):1099-102. PubMed ID: 10582760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coeliac activity of the gliadin peptides CT-1 and CT-2.
    Wieser H; Belitz HD; Idar D; Ashkenazi A
    Z Lebensm Unters Forsch; 1986 Feb; 182(2):115-7. PubMed ID: 3705771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro digestion of gliadin by gastrointestinal enzymes and by pyrrolidonecarboxylate peptidase.
    Caldwell KA
    Am J Clin Nutr; 1980 Feb; 33(2):293-302. PubMed ID: 6101931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation of coeliac active peptide fractions from gliadin.
    Wieser H; Belitz HD; Ashkenazi A; Idar D
    Z Lebensm Unters Forsch; 1983; 176(2):85-94. PubMed ID: 6405556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mucosal digestion studies of whole gliadin fractions in coeliac disease.
    Cornell HJ
    Ann Clin Biochem; 1990 Jan; 27 ( Pt 1)():44-9. PubMed ID: 2310157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Avenin fails to induce a Th1 response in coeliac tissue following in vitro culture.
    Kilmartin C; Lynch S; Abuzakouk M; Wieser H; Feighery C
    Gut; 2003 Jan; 52(1):47-52. PubMed ID: 12477758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amino acid composition of peptides remaining after in vitro digestion of a gliadin sub-fraction with duodenal mucosa from patients with coeliac disease.
    Cornell HJ
    Clin Chim Acta; 1988 Sep; 176(3):279-89. PubMed ID: 3180479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A decapeptide from durum wheat prevents celiac peripheral blood lymphocytes from activation by gliadin peptides.
    Silano M; Di Benedetto R; Trecca A; Arrabito G; Leonardi F; De Vincenzi M
    Pediatr Res; 2007 Jan; 61(1):67-71. PubMed ID: 17211143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Agglutinating activity of gliadin-derived peptides from bread wheat: implications for coeliac disease pathogenesis.
    Auricchio S; De Ritis G; De Vincenzi M; Mancini E; Minetti M; Sapora O; Silano V
    Biochem Biophys Res Commun; 1984 Jun; 121(2):428-33. PubMed ID: 6547342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural specificities and significance for coeliac disease of wheat gliadin peptides able to agglutinate or to prevent agglutination of K562(S) cells.
    De Vincenzi M; Stammati A; Luchetti R; Silano M; Gasbarrini G; Silano V
    Toxicology; 1998 May; 127(1-3):97-106. PubMed ID: 9699797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Further studies of the in vitro activity of synthetic gliadin peptides in coeliac disease.
    Cornell H; Mothes T
    Biochim Biophys Acta; 1995 Apr; 1270(2-3):168-72. PubMed ID: 7727540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The toxicity of certain cereal proteins in coeliac disease.
    Cornell HJ; Townley RR
    Gut; 1974 Nov; 15(11):862-9. PubMed ID: 4455563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytokine mRNA expression in the mucosa of treated coeliac patients after wheat peptide challenge.
    Kontakou M; Przemioslo RT; Sturgess RP; Limb GA; Ellis HJ; Day P; Ciclitira PJ
    Gut; 1995 Jul; 37(1):52-7. PubMed ID: 7672681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.